Warthausen, Baden-Württemberg, Germany
- Provide strategic leadership and direction for goals, strategy settings & objectives of the global Clinical Pharmacology, DMPK and Non-clinical Safety Science (CPS) organization (China, Germany, Japan, USA) and maintain scientific knowledge within the organizations (for the Therapeutic Areas of Oncology, Inflammation, CNS and Eye Health as well as Cardiometabolic diseases) - Responsible for close cooperation and effective resource management within the global CPS organization - Systematic development of talents and future leaders within CPS, thus playing an essential role for organizational development within BI. Create a performance-based team culture within global CPS with clear accountability and a sense of urgency for achieving results. - Accountable and responsible for the quality and state-of-the-art CPS contributions to protocols, reports, submission documents (e.g. "Summary of Biopharmaceutics" and "Summary of clinical Pharmacology", “Summary of Non-clinical Safety” etc.) and regulatory authority meetings, package inert(s), publications etc.. Responsible for establishing most appropriate development strategy within global CPS (e.g. documented in the Clinical Development Plans). Act as advisor for (non-)clinical development. - As a member of the Innovation Unit Executive Committee: Design, drive and ensure the implementation of innovative concepts in line with Innovation Unit (IU) strategy over the whole drug development Pipeline of Boehringer Ingelheim. Contributing and shaping the overall strategy and direction IU of Boehringer Ingelheim. - As a member of the “Portfolio Steering Board of the IUEC”: Strong contribution to the development of drug candidates from the Research phase to the early clinical development stage and up to NDA submission
- Provide strategic leadership and direction for goals, strategy settings & objectives of the global Clinical Pharmacology organization (China, Germany, Japan, USA) and maintain scientific knowledge within the global Clinical Pharmacology organizations (for the Therapeutic Areas of Oncology, Inflammation, CNS and Rential Health diseases as well as Cardiometabolic diseases) - Responsible for close cooperation and effective ressource management between the Clinical Pharmacology groups - Systematic development of talents and future leaders within TMCP, thus playing an essential role for organizational development within BI. Create a performance-based team culture within global Clinical Pharmacology with clear accountability and a sense of urgency for achieving results. - Accountable and being responsible for the quality and state-of-the-art Clin Pharm contributions to protocols, reports, submission documents (e.g. "Summary of Biopharmaceutics" and "Summary of clinical Pharmacology") and regulatory authority meetings, package inert(s), publications etc.. Responsible for establishing most appropriate development strategy within global Clin Pharm (e.g. documented in the Clinical Development Plans). Act as Clinical Pharmacology advisor for clinical development. - As a member of the TMCP Leadership team: Design, drive and ensure the implementation of innovative concepts in line with TMCP and Innovation Unit (IU) strategy over the whole drug development Pipeline of BI. Besides also contributing and shaping the overall strategy and direction of TMCP and the IU of BI. - As a member of the “Translational Science” Advsiory Board: Strong contribution to the PK/PD translation of drug candidates from the late Research phase to the early clinical development stage
Drug Development Professional with 17 years of pharmaceutical industry experience with in-depth knowledge of Translational Medicine and Clinical Pharmacology aspects of NCEs and NBEs from late research phase up to submission. Experience in the areas of Neurology, Oncology, Cardio-Metabolic, Inflammation, Immunology, Respiratory and Biosimilars. Experienced in various leadership positions within Boehringer Ingelheim. In those roles, I could successfully built scientific organizations, create state of the art operating infrastructures, and have successfully led efforts to improve the culture and value of drug development. Experienced as line manager, matrix team manager and individual contributor. Innovation-minded, data-driven and results-oriented creative leader and strategic thinker with high passion and enthusiasm to develop new promising therapies with an entrepreneurial spirit. Committed to helping patients with high unmet medical need